Takeda Parmaceuticals America, Inc. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Takeda Parmaceuticals America, Inc.

Sort by

Viewing results 1‒25 of 116

Due Diligence
Dealmaking and debauchery return to Bourbon Street Premium content
...It hasn’t been an easy feat in America’s profoundly unequal credit system, Bloomberg writes....
March 18, 2022
Due Diligence
Self-help dealmaking: Simon says let’s go shopping Premium content
...Drop us a line and join the conversation: Due.Diligence@FT.com America’s largest shopping mall owner is buying up its tenants Mall operator Simon Property Group has a problem....
August 20, 2020
FT Live
Infrastructure Investment in Latin America and the Caribbean
Identifying opportunities for investors and asset managers
Wednesday, 12 June237 Park Avenue, New York, NY, USA
News in-depthSuntory Ltd
Cannabis set to pose fresh challenge for Beam Suntory
...Another potential pitfall for Beam, under Japanese ownership, is the impact of North America’s cannabis craze....
May 31, 2019
US & Canadian companies
Japan’s Renesas to acquire US rival IDT in $7.2bn deal
...The latest acquisition contributes to a record year for Japanese outbound deals, led by Takeda Pharmaceutical’s £46bn agreement to buy Irish drugmaker Shire in April....
September 11, 2018
Due Diligence
A deep dive into Japan’s M&A market, a special edition of DD Premium content
...newsletter if you liked it.— The Due Diligence team Follow the FT’s deals team Arash Massoudi in London — @ArashMassoudi Javier Espinoza in London — @JavierespFT James Fontanella-Khan in New York — @JFK_America...
September 27, 2018
News in-depthWeek in Review
Week in review, March 31
...Japanese pharma group Takeda weighs bid for Shire In the latest sign of the revived appetite for dealmaking among drugmakers, Japan’s Takeda Pharmaceutical indicated its interest in buying Shire, the UK-listed...
March 30, 2018
FT Live
Future of Asset Management North America
New models for the next age of fund management
Wednesday, 25 SeptemberNew York, NY, USA
News in-depthCurrencies
Global M&A activity hits new high
...The two Wall Street investment banks were followed by JPMorgan, Citigroup and Bank of America, according to Thomson Reuters data....
September 28, 2018
Mergers & Acquisitions
Praxair sells $6bn in European assets to Japan’s Taiyo
...The European gas market was “stable”, Taiyo said, noting it was second in size only to North America....
July 5, 2018
LexUS & Canadian companies
M&A debt: Extend and pretend Premium content
...Mega deals like Sprint/T-Mobile, Takeda/Shire, and Comcast’s pending conquests have made M&A a crucial driver of the loan market....
May 8, 2018
US & Canadian companies
Investment banks line up rebound in revenues
...Falls for some banks were much worse: Deutsche Bank’s investment banking revenues were down 27 per cent, Bank of America’s were down 13 per cent, Citi and JPMorgan were both down 10 per cent....
May 20, 2018
News in-depthBanks
Record ‘megadeals’ push global takeovers beyond $1.2tn
...In the latest sign of how eager boardrooms are sparking a record number of “megadeals”, Japan’s top drugmaker Takeda revealed it was weighing a $40bn takeover of Irish rival Shire....
March 29, 2018
Due Diligence
Mickey Mouse moves closer to capturing Fox Premium content
...(NYT) Down on Shire Japan’s Takeda continues to face stiff resistance from its own investors as it tries to pull off a risky deal for struggling pharma group Shire....
June 28, 2018
Health sector
Hikma Pharma dims generics outlook again after May cut
...Separately, Hikma disclosed on Thursday that it will expand its licensing and distribution pact with Japan’s Takeda Pharmaceuticals that will add new products to its Middle East and North Africa portfolio...
August 17, 2017
US politics & policy
Big US pharma dealmaking plunges to five-year low
...Thomas Sheehan, head of global healthcare at Bank of America Merrill Lynch, said despite the slowdown the fundamentals for dealmaking remained unchanged and activity was bound to pick up again....
June 12, 2017
Pharmaceuticals sector
Health care stocks fall after Trump comments on drug pricing
...Cancer drug maker Takeda Pharmaceutical, fell 2.6 per cent following Trump’s comments....
January 12, 2017
FT Live
Innovative Lawyers Awards North America
Celebrating innovations from both law firms and in-house teams in the region
Monday, 9 DecemberGotham Hall, Broadway, New York, NY, USA
Special ReportFT Health: Vaccines
Demands of disease drive vaccine science
...This month it completed enrolment of 20,100 children in Latin America and Asia for a large-scale clinical trial of its new vaccine against dengue, an important public health problem in the tropics....
April 18, 2017
US politics & policy
Drug stocks tumble as Trump singles out pharma companies
...In Japan, Takeda Pharmaceutical slid 2.7 per cent, Astellas Pharma fell 3.9 per cent and Shionogi sank 3.7 per cent on Thursday morning, while in Australia biotech company CSL Ltd dropped 1.4 per cent and...
January 12, 2017
News in-depthUK companies
GSK and AstraZeneca prescribe different treatments
...A portfolio of respiratory drugs bought from Takeda of Japan will provide an immediate lift to sales while US biotech companies ZS and Acerta were both acquired with an eye on the longer term....
January 3, 2016
Mergers & Acquisitions
AstraZeneca warns of revenue, earnings drop this year
...Alongside this organic progress, we also continued to invest in our main therapy areas through key agreements with Acerta Pharma, ZS Pharma, and Takeda....
February 4, 2016
Companies By Region
AstraZeneca adds 55% Acerta Pharma stake to swath of deals
...The investment came a day after AstraZeneca agreed to pay Takeda of Japan $575m for a portfolio of respiratory medicines and a month after it bought ZS Pharma, a US biotech company, for $2.7bn....
December 17, 2015
US & Canadian companies
Otsuka to buy US maker of promising Alzheimer drug
...Cash-rich Japanese drugmakers have been on a spending spree ahead of the so-called “patent cliff”, highlighted by Takeda Pharmaceutical’s $13.7bn purchase of Nycomed, the Swiss drugmaker, in 2011....
December 2, 2014
European companies
Japanese drugmakers sit out global M&A party
...“The Japanese market could certainly deserve some further consolidation,” says François-Xavier Roger, chief financial officer of Takeda, Japan’s biggest drugmaker....
June 8, 2014
Michael Skapinker
Pharma and Pfizer’s reputations on the line
...The $9bn punitive damages the US jury imposed on Takeda and Eli Lilly show the anger the industry will face if it doesn’t clean itself up. michael.skapinker@ft.com Twitter: @Skapinker...
May 7, 2014
US & Canadian companies
Teva and Sun Pharma fined $2.15bn for patent breach
...Nycomed, now part of Takeda of Japan, owns the rights to the medicine and licensed it exclusively in the US to Wyeth, which is now part of Pfizer....
June 12, 2013
US & Canadian companies
Aspen Pharmacare agrees Merck plant acquisition
...Takeda of Japan last year acquired Nycomed, bringing it a substantial portfolio of medicines in emerging markets led by Russia. Additional reporting by Andrew Jack in London...
June 27, 2013

Previous pagePage 1 of 5Next page